Sarepta Therapeutics, Inc. (NASDAQ:SRPT) appears in 339 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 14,755,277 | 472,024 | 3.30% | $321,074,830.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 14,283,253 | 1,083,408 | 8.21% | $307,375,600.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 11,810,729 | 993,283 | 9.18% | $254,166,887.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 7,796,535 | 6,390,860 | 454.65% | $167,781,432.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 6,640,692 | 6,640,692 | 0.00% | $144,501,458.00 |
| State Street Corp | 31 Mar, 2026 | 6,613,314 | 13,873 | 0.21% | $143,905,713.00 |
| State Street Corp | 31 Mar, 2026 | 6,599,441 | 1,294,534 | 24.40% | $142,019,970.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,433,112 | -1,363,423 | -17.49% | $138,633,564.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 4,593,195 | 2,151,740 | 88.13% | $99,947,923.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,578,235 | 4,578,235 | 0.00% | $99,622,394.00 |
| FIRST TRUST ADVISORS LP | 31 Mar, 2026 | 4,135,788 | 2,143,211 | 107.56% | $89,994,703.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 3,902,596 | 3,902,596 | 0.00% | $84,920,489.00 |
| Erste Asset Management GmbH | 31 Mar, 2026 | 2,968,945 | 240,000 | 8.79% | $61,289,256.00 |
| Erste Asset Management GmbH | 31 Mar, 2026 | 2,728,945 | 43,000 | 1.60% | $58,726,896.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,596,993 | 684,358 | 35.78% | $56,510,595.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 2,441,455 | 303,691 | 14.21% | $52,540,112.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 2,318,890 | 67,297 | 2.99% | $50,459,046.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 2,251,593 | 268,829 | 13.56% | $48,454,281.00 |
| UBS Group AG | 31 Mar, 2026 | 2,232,459 | 173,758 | 8.44% | $48,578,308.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 2,145,926 | 451,336 | 26.63% | $46,695,356.00 |